MiR-34c-5p plays a protective role in chronic obstructive pulmonary disease via targeting CCL22.

CONCLUSION: MiR-34c-5p may promote inflammation response and maintain the protease-antiprotease balance via targeting CCL22, which provides scientific basis for the clinical treatment of COPD. PMID: 31032652 [PubMed - as supplied by publisher]
Source: Experimental Lung Research - Category: Respiratory Medicine Tags: Exp Lung Res Source Type: research